WebDec 20, 2024 · Alecensa is used to treat a certain type of non-small cell lung cancer that has spread to other parts of the body. Alecensa is used only if your cancer has a … WebApr 4, 2024 · Alecensa (alectinib) is a tyrosine kinase inhibitor (TKI) that works specifically on a protein called anaplastic lymphoma kinase (ALK protein). Tyrosine kinases (TK) help to determine processes such as growth, differentiation, metabolism, and cell death, and are involved in signaling pathways – these are pathways that control and regulate the ...
ALECENSA® (alectinib) and Information for Patients
WebALECENSA is a prescription medicine used to treat people with non-small cell lung cancer that has spread to other parts of the body (mNSCLC) and is caused by an abnormal anaplastic lymphoma kinase (ALK) gene. Your healthcare provider will … Use our financial assistance tool to see which programs may be right for you. If … Before you take ALECENSA, tell your doctor about all of your medical … Patient information: full name, date of birth, mailing address, email, phone (home … ALECENSA may cause serious side effects, including: Liver problems … ALK (anaplastic lymphoma kinase) gene. The ALK gene makes an ALK protein, … Who is ALECENSA® (alectinib) for? ALECENSA is a prescription medicine … By submitting this form, I am requesting information that may be of interest to me … The efficacy and safety of ALECENSA were established in the head-to-head, global, … WebOur small family of miniature poodles located in Minneapolis/St.-Paul, Minnesota. We are proud members of the Twin Cities Poodle Club and we participate in AKC events. holiday travel with pets
ALECENSA (alectinib) Fact Sheet - Genentech
WebALECENSA is a kinase inhibitor indicated for the treatment of patients with anaplastic lymphoma kinase (ALK)-positive, metastatic non -small cell lung cancer (NSCLC) who have progressed on or are intolerant to crizotinib. This indication is approved under accelerated approval based on tumor response WebMay 18, 2016 · Alecensa may cause serious side effects, including: Liver problems (hepatotoxicity). Alecensa may cause liver injury. A doctor will do blood tests at least every 2 weeks for the first 2 months and as needed during treatment with Alecensa. Patients taking Alecensa should tell their doctor right away if they experience any of the following … WebFeb 12, 2024 · Administer ALECENSA until disease progression or unacceptable toxicity. The recommended dose of ALECENSA in patients with severe hepatic impairment … humana medicaid for louisiana